Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Schaefer

Showing results (71-80 of 338) with videos related to

Pageof 34
Sort By:
Arteriosclerosis (Dallas, Tex.)|January 1, 1982
Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery diseaseE J Schaefer, W H Heaton, M G Wetzel, et al.
Archives of Internal Medicine|June 1, 1982
POEMS syndrome: studies in a patient with an IgG-kappa M protein but no polyneuropathyJ S Morrow, E J Schaefer, D P Huston, et al.
FEBS Letters|August 31, 1981
In vitro activation of the enzymic activity of hepatic lipase by apoA-IIC E Jahn, J C Osborne, E J Schaefer, et al.
Annals of Internal Medicine|August 1, 1980
Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease)E J Schaefer, L A Zech, D E Schwartz, et al.
Science (New York, N.Y.)|February 6, 1981
Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein ER E Gregg, L A Zech, E J Schaefer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1996
Apolipoprotein E alleles and risk of coronary disease. A meta-analysisP W Wilson, E J Schaefer, M G Larson, et al.
European Journal of Biochemistry|March 1, 1983
Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitroC E Jahn, J C Osborne, E J Schaefer, et al.
Annals of Internal Medicine|December 1, 1986
Increased risk for vitamin A toxicity in severe hypertriglyceridemiaJ K Ellis, R M Russell, F L Makrauer, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Genetic high density lipoprotein deficiency states and atherosclerosisE J Schaefer, J R McNamara, C J Mitri, et al.
Atherosclerosis|March 1, 1994
Effects of dietary fat saturation on plasma lipoprotein(a) and hepatic apolipoprotein(a) mRNA concentrations in cynomolgus monkeysM E Brousseau, J M Ordovas, R J Nicolosi, et al.
Pageof 34

Showing results (71-80 of 338) with videos related to

Sort By:
Pageof 34
Arteriosclerosis (Dallas, Tex.)|January 1, 1982
Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery diseaseE J Schaefer, W H Heaton, M G Wetzel, et al.
Archives of Internal Medicine|June 1, 1982
POEMS syndrome: studies in a patient with an IgG-kappa M protein but no polyneuropathyJ S Morrow, E J Schaefer, D P Huston, et al.
FEBS Letters|August 31, 1981
In vitro activation of the enzymic activity of hepatic lipase by apoA-IIC E Jahn, J C Osborne, E J Schaefer, et al.
Annals of Internal Medicine|August 1, 1980
Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease)E J Schaefer, L A Zech, D E Schwartz, et al.
Science (New York, N.Y.)|February 6, 1981
Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein ER E Gregg, L A Zech, E J Schaefer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1996
Apolipoprotein E alleles and risk of coronary disease. A meta-analysisP W Wilson, E J Schaefer, M G Larson, et al.
European Journal of Biochemistry|March 1, 1983
Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitroC E Jahn, J C Osborne, E J Schaefer, et al.
Annals of Internal Medicine|December 1, 1986
Increased risk for vitamin A toxicity in severe hypertriglyceridemiaJ K Ellis, R M Russell, F L Makrauer, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Genetic high density lipoprotein deficiency states and atherosclerosisE J Schaefer, J R McNamara, C J Mitri, et al.
Atherosclerosis|March 1, 1994
Effects of dietary fat saturation on plasma lipoprotein(a) and hepatic apolipoprotein(a) mRNA concentrations in cynomolgus monkeysM E Brousseau, J M Ordovas, R J Nicolosi, et al.
Pageof 34